These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34956089)

  • 1. NDRG1 Activity in Fat Depots Is Associated With Type 2 Diabetes and Impaired Incretin Profile in Patients With Morbid Obesity.
    Stafeev I; Sklyanik I; Mamontova E; Michurina S; Shestakova E; Yah'yaev K; Yurasov A; Masnikov D; Sineokaya M; Ratner E; Vorotnikov A; Menshikov M; Parfyonova Y; Shestakova M
    Front Endocrinol (Lausanne); 2021; 12():777589. PubMed ID: 34956089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low AS160 and high SGK basal phosphorylation associates with impaired incretin profile and type 2 diabetes in adipose tissue of obese patients.
    Stafeev IS; Sklyanik IA; Yah'yaev KA; Shestakova EA; Yurasov AV; Karmadonov AV; Chibalin AV; Yu Menshikov M; Vorotnikov AV; Parfyonova YV; Shestakova MV
    Diabetes Res Clin Pract; 2019 Dec; 158():107928. PubMed ID: 31734225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low proliferative potential of adipose-derived stromal cells associates with hypertrophy and inflammation in subcutaneous and omental adipose tissue of patients with type 2 diabetes mellitus.
    Stafeev I; Podkuychenko N; Michurina S; Sklyanik I; Panevina A; Shestakova E; Yah'yaev K; Fedenko V; Ratner E; Vorotnikov A; Menshikov M; Yashkov Y; Parfyonova Y; Shestakova M
    J Diabetes Complications; 2019 Feb; 33(2):148-159. PubMed ID: 30482492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion.
    Mingrone G; Nolfe G; Gissey GC; Iaconelli A; Leccesi L; Guidone C; Nanni G; Holst JJ
    Diabetologia; 2009 May; 52(5):873-81. PubMed ID: 19229515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
    Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
    Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.
    Novaes FS; Vasques AC; Pareja JC; Knop FK; Tura A; Chaim ÉA; Geloneze B
    J Clin Endocrinol Metab; 2015 May; 100(5):1984-8. PubMed ID: 25742514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-cell function, incretin response, and insulin sensitivity of glucose and fat metabolism in obese youth: Relationship to OGTT-time-to-glucose-peak.
    Kim JY; Tfayli H; Bacha F; Lee S; Michaliszyn SF; Yousuf S; Gebara N; Arslanian S
    Pediatr Diabetes; 2020 Feb; 21(1):18-27. PubMed ID: 31677208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of incretin on early-phase insulin secretion and glucose excursion.
    Shen J; Chen Z; Chen C; Zhu X; Han Y
    Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes.
    Geloneze B; de Oliveira Mda S; Vasques AC; Novaes FS; Pareja JC; Tambascia MA
    Metabolism; 2014 Jul; 63(7):922-9. PubMed ID: 24854384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes.
    Lee S; Yabe D; Nohtomi K; Takada M; Morita R; Seino Y; Hirano T
    Endocr J; 2010; 57(2):119-26. PubMed ID: 19881250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incretin effect in obese adolescents with and without type 2 diabetes: impaired or intact?
    Aulinger BA; Vahl TP; Prigeon RL; D'Alessio DA; Elder DA
    Am J Physiol Endocrinol Metab; 2016 May; 310(9):E774-81. PubMed ID: 26979523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.
    Michaliszyn SF; Mari A; Lee S; Bacha F; Tfayli H; Farchoukh L; Ferrannini E; Arslanian S
    Diabetes; 2014 Nov; 63(11):3846-55. PubMed ID: 24947360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose intervention for 12 weeks does not impair glycemic control or incretin hormone responses during oral glucose or mixed meal tests in obese men.
    Matikainen N; Söderlund S; Björnson E; Bogl LH; Pietiläinen KH; Hakkarainen A; Lundbom N; Eliasson B; Räsänen SM; Rivellese A; Patti L; Prinster A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
    Nutr Metab Cardiovasc Dis; 2017 Jun; 27(6):534-542. PubMed ID: 28428027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study.
    Chong SC; Sukor N; Robert SA; Ng KF; Kamaruddin NA
    Front Endocrinol (Lausanne); 2022; 13():961432. PubMed ID: 36157456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
    Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
    Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Older Subjects With β-Cell Dysfunction Have an Accentuated Incretin Release.
    de Jesús Garduno-Garcia J; Gastaldelli A; DeFronzo RA; Lertwattanarak R; Holst JJ; Musi N
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2613-2619. PubMed ID: 29672742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered pattern of the incretin effect as assessed by modelling in individuals with glucose tolerance ranging from normal to diabetic.
    Tura A; Muscelli E; Gastaldelli A; Ferrannini E; Mari A
    Diabetologia; 2014 Jun; 57(6):1199-203. PubMed ID: 24658843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Incretin Hormones After Orthotopic Liver Transplantation.
    Gámán G; Sárváry E; Gelley F; Doros A; Görög D; Fehérvári I; Kóbori L; Wágner L; Máthé Z; Nemes B
    Transplant Proc; 2015 Sep; 47(7):2207-9. PubMed ID: 26361681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.